Functional assays for BRCA1 and BRCA2

Marcelo A. Carvalho, Fergus J Couch, Alvaro N A Monteiro

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Genetic testing for the two major breast cancer susceptibility genes has now been available for several years with more than 70,000 people tested in the USA alone. While the current genetic testing identifies many sequence alterations there are problems with both sensitivity and specificity of the assay. In particular, the genetic testing is limited in its ability to determine which of the many missense mutations identified in BRCA1 and BRCA2 actually predispose to cancer and which are simply neutral alterations. Here we will focus on the limitations in test result interpretation and we will explore how biochemistry and cell biology can help to clarify these issues. Although we limit our discussion to genetic testing of BRCA1 and BRCA2, the problem is common to an expanding group of genes, including ATM and MSH2, in which germ-line missense mutations may also confer increased risk of cancer. Here we advocate the use of functional assays to complement genetic data in the analysis of unclassified missense mutations and propose a set of standards to conduct and interpret these assays.

Original languageEnglish (US)
Pages (from-to)298-310
Number of pages13
JournalInternational Journal of Biochemistry and Cell Biology
Volume39
Issue number2
DOIs
StatePublished - 2007

Fingerprint

Genetic Testing
Assays
Missense Mutation
Testing
Genes
Cytology
Biochemistry
Germ-Line Mutation
Neoplasm Genes
Automatic teller machines
Cell Biology
Neoplasms
Breast Neoplasms
Sensitivity and Specificity

Keywords

  • BRCA1
  • BRCA2
  • Cancer risk
  • Functional assays
  • Unclassified variants

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Functional assays for BRCA1 and BRCA2. / Carvalho, Marcelo A.; Couch, Fergus J; Monteiro, Alvaro N A.

In: International Journal of Biochemistry and Cell Biology, Vol. 39, No. 2, 2007, p. 298-310.

Research output: Contribution to journalArticle

Carvalho, Marcelo A. ; Couch, Fergus J ; Monteiro, Alvaro N A. / Functional assays for BRCA1 and BRCA2. In: International Journal of Biochemistry and Cell Biology. 2007 ; Vol. 39, No. 2. pp. 298-310.
@article{de9c79db974b47cb8def0023fba65b7b,
title = "Functional assays for BRCA1 and BRCA2",
abstract = "Genetic testing for the two major breast cancer susceptibility genes has now been available for several years with more than 70,000 people tested in the USA alone. While the current genetic testing identifies many sequence alterations there are problems with both sensitivity and specificity of the assay. In particular, the genetic testing is limited in its ability to determine which of the many missense mutations identified in BRCA1 and BRCA2 actually predispose to cancer and which are simply neutral alterations. Here we will focus on the limitations in test result interpretation and we will explore how biochemistry and cell biology can help to clarify these issues. Although we limit our discussion to genetic testing of BRCA1 and BRCA2, the problem is common to an expanding group of genes, including ATM and MSH2, in which germ-line missense mutations may also confer increased risk of cancer. Here we advocate the use of functional assays to complement genetic data in the analysis of unclassified missense mutations and propose a set of standards to conduct and interpret these assays.",
keywords = "BRCA1, BRCA2, Cancer risk, Functional assays, Unclassified variants",
author = "Carvalho, {Marcelo A.} and Couch, {Fergus J} and Monteiro, {Alvaro N A}",
year = "2007",
doi = "10.1016/j.biocel.2006.08.002",
language = "English (US)",
volume = "39",
pages = "298--310",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Functional assays for BRCA1 and BRCA2

AU - Carvalho, Marcelo A.

AU - Couch, Fergus J

AU - Monteiro, Alvaro N A

PY - 2007

Y1 - 2007

N2 - Genetic testing for the two major breast cancer susceptibility genes has now been available for several years with more than 70,000 people tested in the USA alone. While the current genetic testing identifies many sequence alterations there are problems with both sensitivity and specificity of the assay. In particular, the genetic testing is limited in its ability to determine which of the many missense mutations identified in BRCA1 and BRCA2 actually predispose to cancer and which are simply neutral alterations. Here we will focus on the limitations in test result interpretation and we will explore how biochemistry and cell biology can help to clarify these issues. Although we limit our discussion to genetic testing of BRCA1 and BRCA2, the problem is common to an expanding group of genes, including ATM and MSH2, in which germ-line missense mutations may also confer increased risk of cancer. Here we advocate the use of functional assays to complement genetic data in the analysis of unclassified missense mutations and propose a set of standards to conduct and interpret these assays.

AB - Genetic testing for the two major breast cancer susceptibility genes has now been available for several years with more than 70,000 people tested in the USA alone. While the current genetic testing identifies many sequence alterations there are problems with both sensitivity and specificity of the assay. In particular, the genetic testing is limited in its ability to determine which of the many missense mutations identified in BRCA1 and BRCA2 actually predispose to cancer and which are simply neutral alterations. Here we will focus on the limitations in test result interpretation and we will explore how biochemistry and cell biology can help to clarify these issues. Although we limit our discussion to genetic testing of BRCA1 and BRCA2, the problem is common to an expanding group of genes, including ATM and MSH2, in which germ-line missense mutations may also confer increased risk of cancer. Here we advocate the use of functional assays to complement genetic data in the analysis of unclassified missense mutations and propose a set of standards to conduct and interpret these assays.

KW - BRCA1

KW - BRCA2

KW - Cancer risk

KW - Functional assays

KW - Unclassified variants

UR - http://www.scopus.com/inward/record.url?scp=33845187523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845187523&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2006.08.002

DO - 10.1016/j.biocel.2006.08.002

M3 - Article

C2 - 16978908

AN - SCOPUS:33845187523

VL - 39

SP - 298

EP - 310

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 2

ER -